Department Of Health Articles & Analysis
131 news found
The New York State Department of Health (NYSDOH) describes enterococci as part of the normal flora in the intestinal tract and also a common cause of nosocomial infections. ...
The New York City Department of Health and Mental Hygiene (NYC Health) warns that tuberculosis (TB) is still a life-threatening problem in the city. ...
This project has been funded in whole or in part with Federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority, under Contract No. 75A50122C00025. ...
ENA-001 is also being developed in an Intramuscular ("IM") formulation in partnership with the Biomedical Advanced Research and Development Authority ("BARDA"), part of the Administration for Strategic Preparedness and Response in the U.S. Department of Health and Human Services (contract number 75A50122C00072). ...
Aktiv Pharma Group (Aktiv) today announced a procurement contract award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). Under this contract (number 75A50122C00082), awarded under the 2004 Project ...
The Funding Supports Development of an Intramuscular ENA-001 From Pre-Clinical Toxicology Through Filing for Approval in the United States Enalare Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to developing novel compounds for the treatment of life-threatening critical care diseases and community medical threats, announced today that it has received a contract from the ...
(SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced the exercise of procurement options under its 75A50118C00019 (19C) contract with the U.S. Department of Health and Human Services for the delivery to the U.S. government of intravenous (IV) formulation of TPOXX treatment courses valued at approximately $26 million . ...
About the National Institute on Drug Abuse (NIDA) NIDA is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug use and addiction. ...
Critical Path Institute is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) and is 54.2% funded by the FDA/HHS, totaling $13,239,950, and 45.8% funded by non-government source(s), totaling $11,196,634. ...
Aktiv Pharma Group (Aktiv) announced today a grant award from the U.S. Department of Defense (DOD) Defense Health Agency (DHA) Joint Program Committee 6/Combat Casualty Care Research Program (JPC-6/CCCRP) [1] for the continued development of a tranexamic acid (TXA) autoinjector, targeting proposed indications related to prehospital treatment of severe bleeding. ...
Surgical has signed the Department of Health and Human Services (HHS) climate pledge initiative NewGen in partnership with the White House to mobilize the healthcare sector to reduce carbon emissions. ...
Vedanta Biosciences received a $5.4 million research award from the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) in 2017 and a contract of up to $76.9 million from the Biomedical Advanced Research and Development Authority (contract number 75A50120C00177) within the U.S. Department of Health and Human Services’ Office of ...
The New York State Department of Health (NYSDOH) reports that in at least one out of every six asthmatics, their condition is caused or made worse by workplace exposures. ...
CytoSorbents will present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 18, 2021. Dr. Phillip Chan, CytoSorbents’ Chief Executive Officer, will present a brief overview of the Company operations and outlook at 11:00 a.m. ...
We also expect to continue working with the UK’s National Health Service (NHS), one of the world’s largest and well-renowned healthcare systems, to educate them on the clinical benefits and cost-effectiveness of our technology. To begin with, we plan to highlight last year’s NICE Medtech innovation briefing on the use of CytoSorb to reduce the risk of bleeding ...
The development and manufacturing of REGEN-COV have been funded in part with federal funds from the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response, under OT number: HHSO100201700020C. ...
According to a December 3, 2021 report from the U.S. Department of Health & Human Services (HHS), available at the HHS website at https://www.hhs.gov, the share of Medicare visits conducted through telehealth in 2020 increased 63-fold, from approximately 840,000 in 2019 to 52.7 million. The report noted that telehealth was particularly helpful in offsetting ...
Its technologies have received non-dilutive grant, contract, and other funding of more than $39.5 million from DARPA, the U.S. Department of Health and Human Services (HHS), the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), the U.S. ...
The new phase will support efforts to develop and obtain FDA clearance to offer the test directly to consumers via prescription; develop a digital companion system designed to interpret test results; and seamlessly connect the patient with providers and public health reporting systems. “Antiviral treatments are now available for COVID and both flu strains, but they are ...
In 2021, LightDeck received a $35M grant from the Department of Defense (DOD), in coordination with the Department of Health and Human Services (HHS), to increase manufacturing capacity of the company’s COVID-19 tests following $5.65M in funding from the Biomedical Advanced Research and Development Authority (BARDA) for test development. ...